secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLENO THERAPEUTICS INC (SLNO)
CIK:        0001484565
Form:       8-K
Filed at:   2024-01-05T23:59:59+00:00
Accession:  0001193125-24-003380
Event type: other_material
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Soleno Therapeutics sets 2024 executive compensation: CEO salary $640K, bonus $500K, equity grants
--------------------------------------------------------------------------------

- CEO Bhatnagar 2024 salary $640K, 2023 bonus $500K, equity: 100K options (50% cliff 1yr) + 150K RSUs (quarterly vest).
- CFO Mackaness salary $460K, bonus $240K, equity: 37K options + 56K RSUs.
- VP Regulatory Hirano salary $375K, bonus $153K, equity: 16K options + 24K RSUs.
- Salary increases effective Jan 1, 2024; bonuses for FY2023.
- Options vest 50% on first anniversary, then monthly; RSUs vest quarterly in 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524003380/0001193125-24-003380-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1484565/000119312524003380/d111987d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-003380

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer